MEI Pharma, Inc. (MEIP): Price and Financial Metrics

MEI Pharma, Inc. (MEIP): $2.80

0.08 (+2.94%)

POWR Rating

Component Grades














  • MEIP scores best on the Value dimension, with a Value rank ahead of 84.32% of US stocks.
  • MEIP's strongest trending metric is Momentum; it's been moving down over the last 47 weeks.
  • MEIP's current lowest rank is in the Growth metric (where it is better than 3.56% of US stocks).

MEIP Stock Summary

  • Of note is the ratio of MEI Pharma Inc's sales and general administrative expense to its total operating expenses; just 12.73% of US stocks have a lower such ratio.
  • For MEIP, its debt to operating expenses ratio is greater than that reported by just 12.35% of US equities we're observing.
  • With a price/sales ratio of 12.66, MEI Pharma Inc has a higher such ratio than 85.7% of stocks in our set.
  • Stocks that are quantitatively similar to MEIP, based on their financial statements, market capitalization, and price volatility, are CTMX, GLYC, SGMO, JNCE, and CRUS.
  • Visit MEIP's SEC page to see the company's official filings. To visit the company's web site, go to

MEIP Valuation Summary

  • MEIP's price/sales ratio is 7.7; this is 102.63% higher than that of the median Healthcare stock.
  • MEIP's price/sales ratio has moved down 5976.2 over the prior 215 months.
  • Over the past 215 months, MEIP's price/sales ratio has gone down 5976.2.

Below are key valuation metrics over time for MEIP.

Stock Date P/S P/B P/E EV/EBIT
MEIP 2021-08-31 7.7 7.0 -5.0 -2.5
MEIP 2021-08-30 7.8 7.1 -5.0 -2.6
MEIP 2021-08-27 7.6 6.9 -4.9 -2.4
MEIP 2021-08-26 7.3 6.7 -4.7 -2.3
MEIP 2021-08-25 7.4 6.7 -4.8 -2.3
MEIP 2021-08-24 7.6 6.9 -4.9 -2.5

MEIP Growth Metrics

  • Its 5 year net income to common stockholders growth rate is now at 13.54%.
  • Its year over year net income to common stockholders growth rate is now at -158.65%.
  • Its 2 year net income to common stockholders growth rate is now at 2.67%.
MEIP's revenue has moved up $2,735,000 over the prior 52 months.

The table below shows MEIP's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 25.535 -31.964 -50.575
2021-03-31 40.923 48.405 -63.335
2020-12-31 39.749 53.756 -36.351
2020-09-30 31.59 39.225 -45.114
2020-06-30 28.913 34.258 -46.016
2020-03-31 4.539 -42.918 -24.487

MEIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MEIP has a Quality Grade of C, ranking ahead of 53.89% of graded US stocks.
  • MEIP's asset turnover comes in at 0.131 -- ranking 238th of 677 Pharmaceutical Products stocks.
  • GNCA, BLUE, and NERV are the stocks whose asset turnover ratios are most correlated with MEIP.

The table below shows MEIP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.131 0.945 -34.832
2021-03-31 0.201 0.954 -23.189
2020-12-31 0.220 0.941 -19.061
2020-09-30 0.201 0.921 -34.437
2020-06-30 0.240 0.908 10.741
2020-03-31 0.051 0.275 3.585

MEIP Price Target

For more insight on analysts targets of MEIP, see our MEIP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.67 Average Broker Recommendation 1.39 (Strong Buy)

MEIP Stock Price Chart Interactive Chart >

Price chart for MEIP

MEIP Price/Volume Stats

Current price $2.80 52-week high $4.57
Prev. close $2.72 52-week low $2.40
Day low $2.66 Volume 328,350
Day high $2.81 Avg. volume 686,314
50-day MA $2.73 Dividend yield N/A
200-day MA $3.13 Market Cap 315.50M

MEI Pharma, Inc. (MEIP) Company Bio

MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer. The company was founded in 2000 and is based in San Diego, California.

MEIP Latest News Stream

Event/Time News Detail
Loading, please wait...

MEIP Latest Social Stream

Loading social stream, please wait...

View Full MEIP Social Stream

Latest MEIP News From Around the Web

Below are the latest news stories about MEI Pharma Inc that investors may wish to consider to help them evaluate MEIP as an investment opportunity.

Companies Like MEI Pharma (NASDAQ:MEIP) Are In A Position To Invest In Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Yahoo | September 7, 2021

MEI Pharma Reports Fiscal Year 2021 Results and Operational Highlights

SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year ended June 30, 2021. "Fiscal year 2021 was very successful for MEI; it was highlighted by

PR Newswire | September 2, 2021

MEI Pharma, Inc. (MEIP) Reports Break-Even Earnings for Q4

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 100.00% and 95.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | September 2, 2021

MEI Pharma to Present at Two Healthcare Conferences

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will present a company overview and business update at two upcoming investor conferences:

Yahoo | September 2, 2021

MEI Pharma to Release 2021 Fiscal Year End Financial Results and Provide Corporate Update on September 2, 2021

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that the Company will release its 2021 fiscal year end financial results after the close of the U.S. financial markets on September 2, 2021. The Company will host a conference call and live webcast with the investment community to provide a corporate overview and update the same day at 5:00 p.m. ET.

Yahoo | August 26, 2021

Read More 'MEIP' Stories Here

MEIP Price Returns

1-mo 5.66%
3-mo -11.95%
6-mo -27.08%
1-year -13.85%
3-year -39.26%
5-year 63.74%
YTD 6.06%
2020 6.45%
2019 -6.06%
2018 25.71%
2017 45.83%
2016 -10.00%

Continue Researching MEIP

Want to see what other sources are saying about MEI Pharma Inc's financials and stock price? Try the links below:

MEI Pharma Inc (MEIP) Stock Price | Nasdaq
MEI Pharma Inc (MEIP) Stock Quote, History and News - Yahoo Finance
MEI Pharma Inc (MEIP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8698 seconds.